Trump increased the rate of a new global tariff to 15 percent, vowing to work around the ruling that invalidated his ...

The Dune franchise has firmly cemented itself as a cinematic powerhouse. Upon its release in 2024, Dune: Part Two became the ...

In this episode of Ask the Expert, Susan J. Schniepp, Nelson Labs, and Siegfried Schmitt, Parexel, discuss the benefits of orphan drug development and how a mid-sized company can work with regulators ...

Everyone has been talking about Ozempic in recent years. You may have seen the name in the news or even know someone who is ...

One challenge is limited commercial synergy. Rare disease markets are often fragmented, with small prescriber bases and ...

A few years ago, you would have found him on the high-gloss sets of Karan Johar’s Rocky Aur Rani Kii Prem Kahaani, working as ...

Forget toys and candy. Here’s how Hollywood got hooked on hygiene product placement.

During the 10-day hearing, the competition watchdog and supermarket giant will fight over what a genuine discount looks like.

Alnylam Pharmaceuticals reports fourth quarter and full-year 2025 results Thursday before the market opens, facing investor scrutiny over whether its flagship cardiomyopathy drug can sustain momentum ...

Toy makers are banking on a slew of blockbuster movies in 2026 to spark fresh demand after President Trump’s tariffs last year left manufacturers reeling.

Hims is breaching the United States patent on semaglutide, the active ingredient in Novo’s blockbuster obesity treatments, Novo argued Monday. The U.S. lawsuit attacks not only Hims’ new strategy to ...

Hims is breaching the U.S. patent on semaglutide, the active ingredient in Novo’s Wegovy obesity treatments, Novo argued ...